[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-362213-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-362213-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","global-population-and-genetic-evidence-on-the-relationships-between-immune-mediated-inflammatory-disease-and-cancer-risk","Global, Population and Genetic Evidence on the Relationships Between Immune-Mediated Inflammatory Disease and Cancer Risk","","Immune-mediated inflammatory disease (IMID) and cancer share underlying mechanisms. The study comprehensively evaluated associations between IMIDs and cancers using a triangulation framework from global burden data, prospective population evidence, and genetic causal inference. Global Burden of Disease (2012–2021) assessed six IMIDs and 33 cancers, while UK Biobank validated results with Cox models. FinnGen and UK Biobank Mendelian Randomization tested causal effects, identifying specific IMID–cancer pairs and supporting cancer prevention insights.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/global-population-and-genetic-evidence-on-the-relationships-between-immune-mediated-inflammatory-disease-and-cancer-risk/362213/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/global-population-and-genetic-evidence-on-the-relationships-between-immune-mediated-inflammatory-disease-and-cancer-risk/362213.png","ImageObject",300,407,{"name":42,"@type":43},"River Wang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main purpose of the study about IMID and cancer?","Question",{"text":63,"@type":64},"To comprehensively evaluate the associations between immune-mediated inflammatory diseases and cancers from global, population, and genetic perspectives.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the associations between IMIDs and cancers assessed?",{"text":68,"@type":64},"A triangulation framework was used: Global Burden of Disease data (2012–2021), validation in the UK Biobank cohort using Cox proportional hazards models, and causal inference with genetic instruments via Mendelian Randomization in FinnGen and UK Biobank.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the results identify regarding IMID–cancer relationships?",{"text":72,"@type":64},"IMIDs showed positive associations with cancer occurrence globally, and 170 specific IMID–cancer pairs were significant. Twenty pairs were further confirmed in the UK Biobank, including several strong examples such as atopic dermatitis with Hodgkin lymphoma.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},362213,1790212074,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":124,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Cancer Innovation   \n ORIGINAL ARTICLE   \nGlobal, Population and Genetic Evidence on the Relationships Between Immune‐Mediated Inflammatory Disease and Cancer Risk  \nXuesi Dong1,2 | Jiaxin Xie1,2 | Zilin Luo1,2 | Hao Hong3,4,5 | Chenran Wang1,2 | Yadi Zheng1,2 | Xiaoyue Shi1,2 |  \nZeming Guo1,2 | Xiaolu Chen1,2 | Yongjie Xu1,2 | Wei Cao1,2 | Fei Wang1,2 | Dong Hang6 | Sipeng Shen3,4,5 | Fengwei Tan7 | Ni Li1,2,6   \n1Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China | 2Chinese Academy of Medical Sciences Key Laboratory for National Cancer Big Data Analysis and Implement, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China | 3Department of Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China | 4Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu, China | 5Changzhou Institute for Advanced Study of Public Health, Nanjing Medical University, Changzhou, Jiangsu, China | 6Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China | 7Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China  \nCorrespondence: Sipeng Shen ([sshen@njmu.edu.cn](sshen@njmu.edu.cn)) | Fengwei Tan ([tanfengwei@cicams.ac.cn](tanfengwei@cicams.ac.cn)) | Ni Li ([nli@cicams.ac.cn](nli@cicams.ac.cn))  \nReceived: 26 May 2025 | Revised: 15 October 2025 | Accepted: 22 December 2025  \nFunding: National Natural Science Foundation of China, Grant/Award Numbers: 82404340, 82273722, 82373685, 82204143; CAMS Innovation Fund for Medical Science, Grant/Award Number: 2021‐I2M‐1‐067; Open Research Fund Programme of Changzhou Institute for Advanced Study of Public Health, Nanjing Medical University, Grant/Award Number: CPHM202301  \nKeywords: cancer | epidemiology | evidence triangulation | immune‐mediated inflammatory diseases  \nABSTRACT  \nBackground: Immune‐mediated inflammatory disease (IMID) and cancer share underlying mechanisms. We aimed to comprehensively evaluate the associations between IMIDs and cancers from global, population and genetic perspectives. Methods: A triangulation framework was employed to assess the association between IMIDs and cancers, using the Global Burden of Disease Study (2012–2021) to analyse six IMIDs and 33 cancers. The UK Biobank (UKBB) prospective cohort was subsequently used to validate these associations, with hazard ratios (HRs) and 95% confidence intervals (CIs) estimated by Cox proportional hazards models. Causal inference based on genetic instruments was performed in the FinnGen and UKBB to assess the potential causal effects between IMIDs and cancers.  \nResults: IMIDs were positively associated with the occurrence of cancers from a global perspective. Moreover, 170 specific IMID‐cancer pairs revealed statistically significant associations. A total of 20 pairs of specific IMID‐cancer associations were further confirmed in the UKBB cohort. Among these, the five most pronounced associations included atopic dermatitis with Hodgkin lymphoma (HR = 12.56, 95% CI: 1.76–89.59), with ovarian cancer (HR = 5.65, 95% CI: 1.41–22.65) and with non‐Hodgkin lymphoma (HR = 5.11, 95% CI: 1.91–13.63); rheumatoid arthritis with Hodgkin lymphoma (HR = 3.85, 95% CI:  \n\n| Abbreviations: BMI, body mass index; CI, confidence interval; FDR, false discovery rate; GBD, Global Burden of Disease; GWAS, Genome‐Wide Association Study; HAQ, Healthcare Access and Quality; HR, hazard ratio; ICD‐","cbCainpmUUftSXKt","https://ap.wps.com/l/cbCainpmUUftSXKt","pdf",2273276,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What is the main purpose of the study about IMID and cancer?\",\"answer\":\"To comprehensively evaluate the associations between immune-mediated inflammatory diseases and cancers from global, population, and genetic perspectives.\"},{\"question\":\"How were the associations between IMIDs and cancers assessed?\",\"answer\":\"A triangulation framework was used: Global Burden of Disease data (2012–2021), validation in the UK Biobank cohort using Cox proportional hazards models, and causal inference with genetic instruments via Mendelian Randomization in FinnGen and UK Biobank.\"},{\"question\":\"What did the results identify regarding IMID–cancer relationships?\",\"answer\":\"IMIDs showed positive associations with cancer occurrence globally, and 170 specific IMID–cancer pairs were significant. Twenty pairs were further confirmed in the UK Biobank, including several strong examples such as atopic dermatitis with Hodgkin lymphoma.\"}]","Global, Population and Genetic Evidence on the Relationships Between Immune-Mediated Inflammatory Disease and Cancer Risk | PDF",1790146793,25,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/95042c0eabe59accfead3da3e77dafeb.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/581078c8de6725e5420a2e185e728e19.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9489db53e4c5347d68f138fe3ff6ea37.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8db686b00c3a5486bbf00c60bab56201.webp",980,1287]